Brazil study suggests AstraZeneca vaccine is effective against Brazil COVID-19 variant

Reuters

Published Mar 08, 2021 01:05PM ET

RIO DE JANEIRO (Reuters) - Preliminary studies suggest the AstraZeneca (NASDAQ:AZN) vaccine will protect against the P1 variant of the coronavirus, Mauricio Zuma, the head of production at Brazil's Fiocruz biomedical institute said on Monday, confirming a Reuters report on Friday.